rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2005-12-23
|
pubmed:abstractText |
Extended daily dialysis (EDD) combines the advantage of both intermittent hemodialysis and continuous renal replacement therapy: excellent detoxification accompanied by cardiovascular tolerability. The aim of this study was to evaluate pharmacokinetics of meropenem and vancomycin in critically ill patients with renal failure undergoing EDD.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0090-3493
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
51-6
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:16374156-Acute Kidney Injury,
pubmed-meshheading:16374156-Adult,
pubmed-meshheading:16374156-Aged,
pubmed-meshheading:16374156-Critical Care,
pubmed-meshheading:16374156-Dose-Response Relationship, Drug,
pubmed-meshheading:16374156-Drug Administration Schedule,
pubmed-meshheading:16374156-Drug Monitoring,
pubmed-meshheading:16374156-Female,
pubmed-meshheading:16374156-Follow-Up Studies,
pubmed-meshheading:16374156-Humans,
pubmed-meshheading:16374156-Intensive Care Units,
pubmed-meshheading:16374156-Male,
pubmed-meshheading:16374156-Middle Aged,
pubmed-meshheading:16374156-Prospective Studies,
pubmed-meshheading:16374156-Renal Dialysis,
pubmed-meshheading:16374156-Risk Assessment,
pubmed-meshheading:16374156-Thienamycins,
pubmed-meshheading:16374156-Treatment Outcome,
pubmed-meshheading:16374156-Vancomycin
|
pubmed:year |
2006
|
pubmed:articleTitle |
Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
|
pubmed:affiliation |
Department of Medicine, Division of Nephrology, Medical School Hannover, Hannover, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|